Follow
← Back
Medicines · Interactions

Capecitabine — interactions

Other medicines, foods and herbal products can change how Capecitabine works. Everything on this page comes from Capecitabine's own FDA-approved label — the same source as the main guide.

← Back to the full Capecitabine guide

⚠ Caution: • Allopurinol: Avoid concomitant use of allopurinol with capecitabine tablets. • Leucovorin : Closely monitor for toxicities when capecitabine tablets is coadministered with leucovorin. • CYP2C9 substrates : Closely monitor for adverse reactions when CYP2C9 substrates are coadministered with capecitabine tablets.

Medicines named in Capecitabine's label

Grouped the way the label groups them. Each name links to that medicine's NepalDoc guide; where the label names a class instead of a medicine, the label's words are quoted.

Effect of Other

Drugs on Capecitabine Tablets Allopurinol Concomitant use with allopurinol may decrease concentration of capecitabine’s active metabolites , which may decrease efficacy. Avoid concomitant use of allopurinol with capecitabine tablets. Leucovorin The concentration of fluorouracil is increased and its toxicity may be enhanced by leucovorin, folic acid, or folate analog products.

Section 7.2 of the label

Effect of Capecitabine Tablets on Other Drugs CYP2C9 Substrates Capecitabine tablets increased exposure of CYP2C9 substrates , which may increase the risk of adverse reactions related to these substrates.

Section 7.3 of the label

Nephrotoxic Drugs Due of the additive pharmacologic effect, concomitant use of capecitabine tablets with other drugs known to cause renal toxicity may increase the risk of renal toxicity .

Capecitabine's label names 5 medicines that NepalDoc also covers.

Their interaction pages

These medicines named in Capecitabine's label have interaction pages of their own:

Food, drink & herbs in the label

Vitamin K foods

• Vitamin K antagonists : Monitor INR more frequently and dose adjust oral vitamin K antagonist as appropriate • Phenytoin : Closely monitor phenytoin levels in patients taking capecitabine tablets concomitantly with phenytoin and adjust the phenytoin dose as appropriate. Vitamin K Antagonists Capecitabine tablets increases exposure of vitamin K antagonist , which may alter coagulation parameters and/or bleeding and could result in death .

Read the full interactions section from Capecitabine's label

• Allopurinol: Avoid concomitant use of allopurinol with capecitabine tablets. • Leucovorin : Closely monitor for toxicities when capecitabine tablets is coadministered with leucovorin. • CYP2C9 substrates : Closely monitor for adverse reactions when CYP2C9 substrates are coadministered with capecitabine tablets. • Vitamin K antagonists : Monitor INR more frequently and dose adjust oral vitamin K antagonist as appropriate • Phenytoin : Closely monitor phenytoin levels in patients taking capecitabine tablets concomitantly with phenytoin and adjust the phenytoin dose as appropriate. • Nephrotoxic drugs : Closely monitor for signs of renal toxicity when capecitabine tablets is used concomitantly with nephrotoxic drugs.

7.1 Effect of Other Drugs on Capecitabine Tablets Allopurinol Concomitant use with allopurinol may decrease concentration of capecitabine’s active metabolites , which may decrease efficacy. Avoid concomitant use of allopurinol with capecitabine tablets. Leucovorin The concentration of fluorouracil is increased and its toxicity may be enhanced by leucovorin, folic acid, or folate analog products. Deaths from severe enterocolitis, diarrhea, and dehydration have been reported in elderly patients receiving weekly leucovorin and fluorouracil. Instruct patients not to take products containing folic acid or folate analog products unless directed to do so by their healthcare provider.

7.2 Effect of Capecitabine Tablets on Other Drugs CYP2C9 Substrates Capecitabine tablets increased exposure of CYP2C9 substrates , which may increase the risk of adverse reactions related to these substrates. Closely monitor for adverse reactions of CYP2C9 substrates where minimal concentration changes may lead to serious adverse reactions when used concomitantly with capecitabine tablets (e.g., anticoagulants, antidiabetic drugs). Vitamin K Antagonists Capecitabine tablets increases exposure of vitamin K antagonist , which may alter coagulation parameters and/or bleeding and could result in death . These events may occur within days of treatment initiation and up to 1 month after discontinuation of capecitabine tablets. Monitor INR more frequently and refer to the prescribing information of oral vitamin K antagonist for dosage adjustment, as appropriate, when capecitabine tablets is used concomitantly with vitamin K antagonist. Phenytoin Capecitabine tablets may increases exposure of phenytoin, which may increase the risk of adverse reactions related to phenytoin. Closely monitor phenytoin levels and refer to the prescribing information of phenytoin for dosage adjustment, as appropriate, when capecitabine tablets is used concomitantly with phenytoin.

7.3 Nephrotoxic Drugs Due of the additive pharmacologic effect, concomitant use of capecitabine tablets with other drugs known to cause renal toxicity may increase the risk of renal toxicity . Closely monitor for signs of renal toxicity when capecitabine tablets is used concomitantly with nephrotoxic drugs (e.g. platinum salts, irinotecan, methotrexate, intravenous bisphosphonates).

Capecitabine guide · All interaction pages · Medicines A–Z

SourcesU.S. FDA-approved label via DailyMed (label effective 20 Nov 2025) · National List of Essential Medicines, Nepal (2021) · U.S. labeling may differ from Nepal DDA-approved labeling and local prescribing practice.

This page summarises Capecitabine's FDA-approved label for information — it is not medical advice. Always tell your doctor or pharmacist about every medicine, supplement and herbal product you take.

Search medicines in the app / एपमा औषधि खोज्नुहोस् Find a pharmacy / फार्मेसी खोज्नुहोस्
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.

Share this Medicine
NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.